Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPremier Fund Managers Ltd
Latest Disclosed Ownership5,672 shares
Latest Disclosed Value $ 774
Premier Fund Managers Ltd reports 24.52% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Premier Fund Managers Ltd filed a 13F-HR form disclosing ownership of 5,672 shares of Gilead Sciences, Inc. (CH:GILD) valued at $774 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 7,515 shares of Gilead Sciences, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 5,672 -1,843 -24.52 1 0.0548
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 7,515 -1,000 -11.74 1 0.0533
2025-11-10 2025-09-30 13F GILEAD SCIENCES COM 375558103 8,515 -1,300 -13.25 1 -100.00 0.0394
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 9,815 600 6.51 1 0.00 0.0396
2025-05-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 9,215 -6,495 -41.34 1 0.00 0.0385
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 15,710 5,000 46.69 1 0.0515
2024-11-08 2024-09-30 13F GILEAD SCIENCES COM 375558103 10,710 0 0.00 1 0.0318
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 10,710 0 0.00 1 0.0296
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 10,710 846 8.58 1 0.0310
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 9,864 -800 -7.50 1 0.0345
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 10,664 0 0.00 1 0.0378
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 10,664 0 0.00 1 0.0322
2023-05-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 10,664 1,518 16.60 1 0.0344
2023-02-09 2022-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 9,146 400 4.57 1 -100.00 0.0303
2023-02-08 2022-12-31 13F GILEAD SCIENCES COM 375558103 193,323 184,577 10 0.3790
2022-11-04 2022-09-30 13F GILEAD SCIENCES COM 375558103 8,746 3,346 61.96 552 63.80 0.0412
2022-08-09 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 5,400 900 20.00 337 25.28 0.0150
2022-08-08 2022-06-30 13F GILEAD SCIENCES COM 375558103 5,400 900 1,713 0.0922
2022-05-10 2022-03-31 13F GILEAD SCIENCES COM 375558103 4,500 0 0.00 269 -18.48 0.0094
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 4,500 500 12.50 330 16.20 0.0106
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 4,000 0 0.00 284 4.41 0.0092
2021-08-05 2021-06-30 13F GILEAD SCIENCES COM 375558103 4,000 0 0.00 272 3.82 0.0092
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 4,000 -16,204 -80.20 262 -77.10 0.0101
2021-02-09 2020-12-31 13F GILEAD SCIENCES COM 375558103 20,204 1,843 10.04 1,144 0.35 0.0494
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 18,361 0 0.00 1,140 -16.73 0.0654
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 18,361 -57,487 -75.79 1,369 -76.21 0.0852
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 75,848 75,848 5,755 3.7267
2018-08-10 2018-06-30 13F GILEAD SCIENCES COM 375558103 0 -41,129 -100.00 0 -100.00
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 41,129 0 0.00 3,076 3.19 2.5455
2018-02-13 2017-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 41,129 1,202 3.01 2,981 -7.71 2.1814
2018-02-09 2017-12-31 13F GILEAD SCIENCES COM 375558103 57,135 17,208 2,981
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 39,927 3,662 10.10 3,230 25.68 2.3312
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 36,265 0 0.00 2,570 4.94 2.0876
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 36,265 4,762 15.12 2,449 7.79 2.1120
2017-02-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 31,503 26,303 505.83 2,272 460.99 1.9594
2016-11-10 2016-09-30 13F GILEAD SCIENCES COM 375558103 5,200 -27,000 -83.85 405 -84.71 0.3290
2016-07-28 2016-06-30 13F GILEAD SCIENCES COM 375558103 32,200 5,200 19.26 2,649 6.69 2.5781
2016-05-13 2016-03-31 13F GILEAD SCIENCES COM 375558103 27,000 2,500 10.20 2,483 -0.80 2.4209
2016-05-13 2015-12-31 13F GILEAD SCIENCES COM 375558103 24,500 24,500 2,503 2.3498
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.